A Population of Selected Renal Cells Augments Renal Function and Extends Survival in the ZSF1 Model of Progressive Diabetic Nephropathy
New treatment paradigms that slow or reverse progression of chronic kidney disease (CKD) are needed to relieve significant patient and healthcare burdens. We have shown that a population of selected renal cells (SRCs) stabilized disease progression in a mass reduction model of CKD. Here, we further...
Main Authors: | Rusty Kelley Ph.D., Andrew Bruce, Tom Spencer, Eric Werdin, Roger Ilagan, Sumana Choudhury, Elias Rivera, Shay Wallace, Kelly Guthrie, Manuel Jayo, Fengfeng Xu, Anjali N. Rao, Benjamin D. Humphreys, Sharon Presnell, Tim Bertram |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-06-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X653237 |
Similar Items
-
High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.
by: Ken Dower, et al.
Published: (2017-01-01) -
A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats.
by: Pierre E Signore, et al.
Published: (2021-01-01) -
A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats
by: Pierre E. Signore, et al.
Published: (2021-01-01) -
Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome
by: Marta Borges-Canha, et al. -
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
by: Michal Herman-Edelstein, et al.
Published: (2014-03-01)